Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer

BACKGROUND: Despite the great achievements made in immune-checkpoint-blockade (ICB) in cancer therapy, there are no effective predictive biomarkers in gastrointestinal (GI) cancer. METHODS: This study included 93 metastatic GI patients treated with ICBs. The first cohort comprising 73 GI cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhihao, Chen, Huan, Li, Shuang, Gong, Jifang, Li, Jian, Zou, Jianling, Wu, Lihong, Yu, Jianing, Han, Wenbo, Sun, Huaibo, Jiao, Xi, Zhang, Xiaotian, Peng, Zhi, Lu, Ming, Wang, Zhenghang, Zhang, Henghui, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430454/
https://www.ncbi.nlm.nih.gov/pubmed/32792358
http://dx.doi.org/10.1136/jitc-2019-000374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430454/
https://www.ncbi.nlm.nih.gov/pubmed/32792358
http://dx.doi.org/10.1136/jitc-2019-000374

Ejemplares similares